Resources » Publications
The 2013-2014 Progress Report highlights the year's incredible achievements and advancements made on behalf of melanoma patients and our continued strategy to build upon innovative developments in the field.
The MRA Brochure features the ways in which MRA is working toward a cure through cutting-edge research, collaboration with all stakeholders to amplify our reach, and policy change to leverage progress for the entire field of melanoma.
From February 26-28, MRA welcomed more than 300 leaders from academia, industry, nonprofits, and government to Washington, DC, for two days of intensive meetings on all things melanoma at the 6th Annual Scientific Retreat. The meeting was electric with optimism and potential for life-saving progress. As scientists presented their research findings, explored collaborations across disciplines and sectors, and engaged in discussions about improving patient outcomes, it was apparent that we are turning the corner on melanoma.
The 2012-2013 Snapshot of Progress reflects on the organization's accomplishments and the impact of MRA-funded programs during this pivotal time in melanoma research.
The Melanoma Research Alliance (MRA) works closely with public policy leaders, catalyzing efforts to propel strategic policy initiatives that can advance the fight against melanoma. This document provides an overview of current policy initiatives.
MRA convened its Fifth Annual Scientific Retreat in Washington, DC, February 27-28, 2013. The retreat brought together nearly 200 leading scientists and clinicians from around the world, as well as senior leadership from nonprofit foundations, corporate allies, government agencies, industry, and other key stakeholders to share early findings, identify future directions, discuss ideas, and look for synergies and partnerships.
The MRA brochure features ways in which MRA is working toward a cure through research, fostering collaboration to amplify our reach, and leveraging progress through policy change.
2011 – 2012 Progress Report puts into perspective all that has been accomplished over the last year and where we are headed in capitalizing on the progress in prevention, detection, and treatment of deadly skin cancer.
Stand Up To Cancer (SU2C) and the Melanoma Research Alliance (MRA) have joined forces with a new print public service announcement starring Academy Award® nominee Laura Linney. Headlined “Wear Your Beauty Brilliantly,” the PSA is designed to raise awareness about the life-saving benefits of protecting oneself from harmful exposure to UV rays that increase the risk of being diagnosed with melanoma and is the first element in a “Protect Your Skin” campaign.
MRA's Fourth Annual Scientific Retreat brought together more than 220 thought leaders from academia, industry, government, business, and philanthropy to share latest findings and forge new partnerships in pursuit of better outcomes for patients. This report summarizes the meeting highlights, underscoring the momentum that has occurred due to recent research breakthroughs and opportunities for charting a new course in the fight against melanoma.
The first ever Melanoma Research Alliance Progress Report, Accelerating Progress Toward a Cure for Melanoma: 2008-2011, has been published. The report highlights the accomplishments of MRA's first four years of work, as they were a period of landmark advances in the field of melanoma research and treatment. This report offers a retrospective of the four years since the founding of MRA, including the progress that has occurred as a result of MRA research investments, and a look to the future of melanoma research.
At MRA's Third Annual Scientific Retreat, held Feb. 16-18, 2011, in Washington, DC, MRA hosted discussions of cutting-edge melanoma research results and key policy issues. MRA-funded investigators, including early career scientists, established investigators, and interdisciplinary teams, reported on the progress of their work. The report summarizes the highlights of the meeting, illustrating the progress that has been made as a result of collaborative partnerships to forge pathways towards success in the fight against melanoma.